Unadilla, NY, United States of America

Tammy Talbot Schunk

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: The Procter Gamble Company. Active years: 2009.


% Patents Active = 100.0



Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tammy Talbot Schunk: Innovator in Antibacterial Quinolone Synthesis

Introduction

Tammy Talbot Schunk is a notable inventor based in Unadilla, NY (US). She has made significant contributions to the field of chemistry, particularly in the synthesis of antibacterial quinolone compounds. Her innovative work has led to the development of a unique hydride reduction process that is essential for preparing quinolone intermediates.

Latest Patents

Tammy holds a patent for a hydride reduction process for preparing quinolone intermediates. This hydride process is particularly useful in making acyclic diol intermediates from cyclic intermediates, which are crucial in the synthesis of antibacterial quinolones. Her patent showcases her expertise and commitment to advancing pharmaceutical chemistry.

Career Highlights

Throughout her career, Tammy has worked with prominent companies such as The Procter & Gamble Company and Warner Chilcott Company, LLC. Her experience in these organizations has allowed her to apply her innovative ideas in practical settings, contributing to the development of effective antibacterial agents.

Collaborations

Tammy has collaborated with various professionals in her field, including her coworker Michael Patrick Hayes. These collaborations have enriched her work and expanded the impact of her inventions.

Conclusion

Tammy Talbot Schunk is a pioneering inventor whose work in the hydride reduction process has made significant strides in the synthesis of antibacterial quinolones. Her contributions to the field of chemistry continue to influence the development of important pharmaceutical compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…